Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The lncRNA LOXL1-AS1 may help diagnose and treat androgenic alopecia.

The normalized androgen ratio can help manage conditions with excess androgen activity in women.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Estrogen speeds up hair follicle cell death, causing early hair growth cycle changes, but only if a specific receptor is present.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Blocking testosterone speeds up wound healing in males.

A rare tumor caused unusual hormone production leading to Cushing syndrome.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Ashwagandha may help reduce symptoms of adrenal hyperplasia.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Androgens and DHEA can help prevent breast cancer and improve health in women.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Targeting EGFR may help reduce hair loss from chemotherapy.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.